|
Flinders Academic Commons >
Research Publications >
07 - Biomedical and Clinical Research >
1103 - Clinical Sciences >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2328/10569
|
| Title: | Pharmaceutical benefits scheme criteria for the
use of tumour necrosis factor-alpha inhibitors in the treatment of ankylosing
spondylitis in Australia: are they evidence based? |
| Authors: | Smith, Malcolm Douglas
Ahern, Michael John |
| Issue Date: | 2006 |
| Citation: | Smith, M.D. & Ahern, M.J., 2006.
Pharmaceutical benefits scheme criteria for the use of tumour necrosis factor-alpha
inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence
based?. Internal Medicine Journal, 36(2), 72-76. |
| URI: | http://hdl.handle.net/2328/10569 |
| ISSN: | 1444-0903 |
| Appears in Collections: | 1103 - Clinical Sciences
|
Files in This Item:
There are no files associated with this item.
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
